Conference Reports for NATAP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

Safety, efficacy and tolerability of half-dose Sofosbuvir plus Simeprevir in treatment of Hepatitus C in patients with end stage renal disease       Dr. Kalyan Bhamidimarri et al   Reported by Jules Levin EASL 2015 April 2015